Srinivasan says enrolling patients in clinical trials that best represents their type of kidney cancer is an appropriate course of action for treatment.
Ramaprasad Srinivasan, MD, PhD
Articles by Ramaprasad Srinivasan, MD, PhD
Srinivasan says enrolling patients in clinical trials that best represents their type of kidney cancer is an appropriate course of action for treatment.
